» Articles » PMID: 26392556

Cognate Interaction with INKT Cells Expands IL-10-producing B Regulatory Cells

Overview
Specialty Science
Date 2015 Sep 23
PMID 26392556
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Successful induction of B-cell activation and memory depends on help from CD4+ T cells. Invariant natural killer T (iNKT) cells (glycolipid-specific, CD1d-restricted innate lymphocytes) provide both cognate (direct) and noncognate (indirect) helper signals to enhance B-cell responses. Both forms of iNKT-cell help induce primary humoral immune responses, but only noncognate iNKT-cell help drives humoral memory and plasma cells. Here, we show that iNKT cognate help for B cells is fundamentally different from the help provided by conventional CD4+ T cells. Cognate iNKT-cell help drives an early, unsustained germinal center B-cell expansion, less reduction of T follicular regulatory cells, an expansion of marginal zone B cells, and early increases in regulatory IL-10-producing B-cell numbers compared with noncognate activation. These results are consistent with a mechanism whereby iNKT cells preferentially provide an innate form of help that does not generate humoral memory and has important implications for the application of glycolipid molecules as vaccine adjuvants.

Citing Articles

Expansion of B10 cells : Pathways, techniques and applications in transplantation (Review).

Zhao D, Huai G, Yuan Y, Cui Y, Yuan Y, Zhao G Int J Mol Med. 2024; 55(2).

PMID: 39670296 PMC: 11670864. DOI: 10.3892/ijmm.2024.5470.


The iNKT cell ligand α-GalCer prevents murine septic shock by inducing IL10-producing iNKT and B cells.

Park Y, Lee S, Kim T, Park H, Van Kaer L, Hong S Front Immunol. 2024; 15:1457690.

PMID: 39355237 PMC: 11442275. DOI: 10.3389/fimmu.2024.1457690.


invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies.

Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin R Front Transplant. 2024; 3:1353803.

PMID: 38993780 PMC: 11235242. DOI: 10.3389/frtra.2024.1353803.


Natural killer T cells in allergic asthma: implications for the development of novel immunotherapeutical strategies.

Gutierrez-Vera C, Garcia-Betancourt R, Palacios P, Muller M, Montero D, Verdugo C Front Immunol. 2024; 15:1364774.

PMID: 38629075 PMC: 11018981. DOI: 10.3389/fimmu.2024.1364774.


Harnessing NKT cells for vaccination.

Burn O, Pankhurst T, Painter G, Connor L, Hermans I Oxf Open Immunol. 2023; 2(1):iqab013.

PMID: 36845569 PMC: 9914585. DOI: 10.1093/oxfimm/iqab013.


References
1.
Chemnitz J, Parry R, Nichols K, June C, Riley J . SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol. 2004; 173(2):945-54. DOI: 10.4049/jimmunol.173.2.945. View

2.
Mauri C, Bosma A . Immune regulatory function of B cells. Annu Rev Immunol. 2012; 30:221-41. DOI: 10.1146/annurev-immunol-020711-074934. View

3.
Galli G, Pittoni P, Tonti E, Malzone C, Uematsu Y, Tortoli M . Invariant NKT cells sustain specific B cell responses and memory. Proc Natl Acad Sci U S A. 2007; 104(10):3984-9. PMC: 1805488. DOI: 10.1073/pnas.0700191104. View

4.
Bryant V, Ma C, Avery D, Li Y, Good K, Corcoran L . Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J Immunol. 2007; 179(12):8180-90. DOI: 10.4049/jimmunol.179.12.8180. View

5.
Yanaba K, Bouaziz J, Haas K, Poe J, Fujimoto M, Tedder T . A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008; 28(5):639-50. DOI: 10.1016/j.immuni.2008.03.017. View